Alanine transaminase (ALT) and aspartate transaminase (AST) were substantially higher in NAFLD (P = 0.02) and NASH (P = 0.02) patients, compared to the healthy group. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.